td-5108 and Parkinsonian-Disorders

td-5108 has been researched along with Parkinsonian-Disorders* in 2 studies

Other Studies

2 other study(ies) available for td-5108 and Parkinsonian-Disorders

ArticleYear
Activation and blockade of serotonin
    Neurological research, 2019, Volume: 41, Issue:7

    Topics: Animals; Benzimidazoles; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine; Dose-Response Relationship, Drug; Habenula; Indoles; Male; Maze Learning; Memory, Short-Term; Microinjections; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Substantia Nigra; Sulfonamides

2019
The 5-HT4 Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo.
    CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:9

    Topics: Animals; Benzofurans; Brain; Dopamine; Dopamine Agents; Functional Laterality; Indoles; Levodopa; Microdialysis; Oxidopamine; Parkinsonian Disorders; Rats; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides

2015